Westlake (NYSE:WLK) 주식

WESTLAKE CORP

Westlake

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

Kazan,,Russia,-,Dec,02,,2021:,Square,,Inc.,Changes,Name

Equities

Large Cap

News

Movers

Trading Ideas

COKE

FSLR

LINE

TRGP

지난주 가장 저조한 실적을 기록한 대형주는 다음과 같다. 블록, 코카콜라, 리니지, 벡톤 디킨슨, 웨스트레이크, 필그림스, 에코페트롤, 알라모스, YPF, 타르가

블록·코카콜라 등 지난주 급락한 대형주 10종목 (4월 28일~5월 2일)

Market,Sentiment,,Fear,And,Greed,Index,,Emotional,On,Stock,Market

Long Ideas

Pre-Market Outlook

Markets

CNN 머니 공포·탐욕 지수는 전반적인 시장 심리가 하락했음을 보여 주었다. 지난 금요일에는 지수가 &#34;공포&#34; 구역으로 이동했다. 미국 주식은 금요일에 하락세로 마감되었으며, 다우존스 지수는 세션 중에 700포인트 이상 하락했다.

경제지표 약세로 다우 지수 700p 급락: 투자 심리 감소, 탐욕 지수는 &#39;공포&#39; 영역으로

Redcliffe,,Queensland,,Australia,-,May,14,2018:,Domino's,Pizza,Store

Earnings

월요일(24일) 아침 미국 주식 선물이 혼조세를 보이면서, 투자자들의 주목을 받을 수 있는 몇 가지 주식은 다음과 같다. 오웬스 코닝, 도미노 피자, 하와이안 일렉트릭, 원오크 및 웨스트레이크

월요일 주목해야 할 주식: 오웬스 코닝, 도미노 피자, 하와이안 일렉트릭, 원오크 및 웨스트레이크

Westlake Corp

WALKABOUT RES LTD by Walkabout Resource Limited

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP

WILK TECHNOLOGIES LTD by WILK TECHNOLOGIES LTD.

Westlake Epoxy Collaborates With Alpha Recyclage Composites To Expand Recycling Capacity For Carbon Fiber Composite Materials

Mizuho analyst John Roberts maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Outperform and lowers the price target from $100 to $82.

Price Target

Analyst Ratings

Mizuho Maintains Outperform on Westlake, Lowers Price Target to $82

Truist Securities analyst Peter Osterland maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy and lowers the price target from $117 to $92.

Truist Securities Maintains Buy on Westlake, Lowers Price Target to $92

Citigroup analyst Patrick Cunningham maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy and lowers the price target from $95 to $85.

Citigroup Maintains Buy on Westlake, Lowers Price Target to $85

RBC Capital analyst Arun Viswanathan maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Outperform and lowers the price target from $96 to $88.

RBC Capital Maintains Outperform on Westlake, Lowers Price Target to $88

UBS analyst Joshua Spector maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy and lowers the price target from $118 to $101.

UBS Maintains Buy on Westlake, Lowers Price Target to $101

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>D. Boral Capital cut Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) price target from $8 to $3. D. Boral Capital analyst Jason Kolbert maintained a Buy rating. Reviva Pharmaceuticals shares closed at $0.8900 on Monday. <a href="https://www.benzinga.com/quote/RVPH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies raised the price target for ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) from $16 to $17. Jefferies analyst Omar Nokta maintained a Hold rating. ZIM Integrated Shipping shares closed at $19.37 on Monday.<a href="https://www.benzinga.com/quote/ZIM/analyst-ratings"> See how other analysts view this stock.</a></li>
<li>Loop Capital cut MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) price target from $350 to $190. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. MongoDB shares closed at $189.01 on Monday. See how other <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">analysts view this stock</a>.</li>
<li>Citigroup raised the price target for Air Lease Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) from $45 to $68. Citigroup analyst Kevin Crissey upgraded the stock from Neutral to Buy. Air Lease shares closed at $57.14 on Monday. <a href="https://www.benzinga.com/quote/AL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS slashed the price target for Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) from $1,530 to $1,350. UBS analyst Dan Leonard upgraded the stock from Neutral to Buy. Mettler-Toledo International shares closed at $1,159.10 on Monday. <a href="https://www.benzinga.com/quote/MTD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) price target from $95 to $76. Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight. Westlake shares settled at $79.94 on Monday. <a href="https://www.benzinga.com/quote/WLK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) price target from $700 to $775. Canaccord Genuity analyst Maria Ripps maintained a Buy rating. Spotify shares closed at $664.62 on Monday. <a href="https://www.benzinga.com/quote/SPOT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays boosted Urban Outfitters, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) price target from $59 to $73. Barclays analyst Adrienne Yih maintained an Overweight rating. Urban Outfitters shares closed at $61.42 on Monday.  <a href="https://www.benzinga.com/quote/URBN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc increased the price target for Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) from $125 to $135. Keybanc analyst Bradley Thomas maintained an Overweight rating. Ollie&#8217;s Bargain Outlet shares settled at $120.75 on Monday. <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) price target from $220 to $235. Baird analyst David George maintained a Neutral rating. JPMorgan shares closed at $264.88 on Monday. <a href="https://www.benzinga.com/quote/JPM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying SPOT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-1024x598.png" alt="" class="wp-image-921252" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45511338/home-depot-toll-brothers-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Toll Brothers And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

OLLI

RVPH

SPOT

URBN

Spotify To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday

BMO Capital analyst John McNulty maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Market Perform and lowers the price target from $103 to $94.

BMO Capital Maintains Market Perform on Westlake, Lowers Price Target to $94

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Philip Gibbs downgraded the rating for ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Overweight to Sector Weight. ATI shares closed at $76.58 on Monday. <a href="https://www.benzinga.com/quote/ATI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Arthur He downgraded Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Buy to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Yun Kim downgraded MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) from Buy to Hold and lowered the price target from $350 to $190. MongoDB shares closed at $189.01 on Monday. <a href="https://www.benzinga.com/quote/AFRMDBM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Eric Joseph downgraded the rating for Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Overweight to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison downgraded the rating for Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Equal-Weight and cut the price target from $95 to $76. Westlake shares closed at $79.94 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratingsWLK">See how other analysts view this stock.</a></li>
</ul>
Considering buying MDB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="563" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png" alt="" class="wp-image-921180" style="width:670px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246.png 1123w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45511338/home-depot-toll-brothers-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Toll Brothers And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Downgrades

PRME

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) underwent analysis by 26 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $114.38, a high estimate of $166.00, and a low estimate of $76.00. This current average has decreased by 14.74% from the previous average price target of $134.15. 
<img src="https://www.benzinga.com/files/images/story/2025/1747742438_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Westlake's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$76.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Neel Kumar</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$98.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$96.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$95.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$103.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$95.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$117.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$103.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$132.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$110.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$127.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$116.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$155.00</td>
<td>$166.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$133.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Neel Kumar</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$122.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$132.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$166.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$116.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Westlake. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Westlake compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Westlake's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Westlake's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WLK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Westlake analyst ratings.</a>
<h2>Get to Know Westlake Better</h2>
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
<h3>Westlake: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Challenges: Westlake's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -4.34%. This indicates a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Westlake's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.41% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Westlake's ROE excels beyond industry benchmarks, reaching -0.38%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Westlake's ROA excels beyond industry benchmarks, reaching -0.19%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.53, Westlake adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Westlake Stock: Analyst Perspectives (26 Ratings)

Wells Fargo analyst Michael Sison downgrades Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Equal-Weight and lowers the price target from $95 to $76.

Wells Fargo Downgrades Westlake to Equal-Weight, Lowers Price Target to $76

Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $105 to $100.

Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $100

WIIM

AVNT

AXTA

CENX

MATV

MEOH

MTUS

PACK

TANH

TROX

Shares of companies within the broader materials sector are trading higher amid overall market strength after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A decrease of trade tensions could reduce demand uncertainty for materials.

Morgan Stanley analyst Neel Kumar maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Equal-Weight and lowers the price target from $122 to $98.

Morgan Stanley Maintains Equal-Weight on Westlake, Lowers Price Target to $98

RBC Capital analyst Arun Viswanathan maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Outperform and lowers the price target from $122 to $96.

RBC Capital Maintains Outperform on Westlake, Lowers Price Target to $96

Goldman Sachs analyst Duffy Fischer maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $130 to $95.

Goldman Sachs Maintains Neutral on Westlake, Lowers Price Target to $95

JP Morgan analyst Jeffrey Zekauskas maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $110 to $82.

JP Morgan Maintains Neutral on Westlake, Lowers Price Target to $82

BMO Capital analyst John McNulty maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Market Perform and lowers the price target from $125 to $103.

BMO Capital Maintains Market Perform on Westlake, Lowers Price Target to $103

Wells Fargo analyst Michael Sison maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Overweight and lowers the price target from $110 to $95.

Wells Fargo Maintains Overweight on Westlake, Lowers Price Target to $95

Barclays analyst Michael Leithead maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Overweight and lowers the price target from $135 to $100.

Comments

Westlake

뉴스

파트너 / 기고자

벤징가 글로벌